Here is a great dementia resource for caregivers and healthcare professinals,
Here is information on being the best caregiver you can be
Here is a way for nurses administrators, social workers and other health care professionals to get an easyceu or two
By John Gever, Senior Editor, MedPage Today
Blocked blood vessels in the brain, often too small to be seen with current medical imaging technologies, may explain some of the common signs of aging such as diminished walking ability and hand tremors, researchers said.
Brain autopsy findings showed microscopic infarcts in 57 individuals out of 418 examined, the presence of which was significantly associated with gait abnormalities similar to those seen in Parkinson's disease, reported Aron S. Buchman, MD, of Rush University in Chicago, and colleagues.
Signs of arteriolosclerosis invisible with standard imaging were also significantly associated witparkinsonian gait, as were macroscopic infarcts that would be picked up with CT or MRI scans, the researchers indicated online in Stroke: Journal of the American Heart Association.
"We are not aware of previous studies demonstrating independent roles for microinfarcts and the severity of arteriolosclerosis in the development of parkinsonian gait," Buchman and colleagues wrote.
"Given that microinfarcts and severity of arteriolosclerosis are not discernible during life, these pathologies likely represent unrecognized common etiologies for parkinsonian gait in older persons and support clinical-imaging studies that suggest subclinical cerebrovascular disease abnormalities are associated with gait dysfunction in older persons."
The researchers added that more aggressive prevention and treatment strategies for vascular risk factors "might decrease the burden of mild age-related parkinsonian signs."
Such symptoms, which include rigidity and sluggish movements as well as tremors and gait problems -- are common in the elderly, affecting up to half of noninstitutionalized people 85 and older, according to Buchman and colleagues.
They pointed out that, although these symptoms are shared with Parkinson's disease (hence the "parkinsonian" rubric), most individuals showing them do not have the disease, as Lewy bodies and nigral degeneration, its neurological hallmarks, are absent.
On the other hand, cerebrovascular defects are common in older people and are known to produce parkinsonian symptoms, the researchers indicated.
To explore the connection, they reviewed autopsy findings from 418 deceased participants in the Rush Religous Orders Study, a prospective study that began in 1993 involving some 1,100 older nuns, brothers, and priests who underwent annual physical and psychological exams.
Those included in the current analysis had no signs of dementia at enrollment. At death, they averaged 88.5 years old and about 60% were women. Mean scores on the Mini-Mental State Examination at their last visit were 22.7, indicating significant cognitive impairment.
Microscopic infarcts were present without other abnormalities in 7.9%, and accompanied by arteriolosclerosis not detected in brain scans in 5.7%.
These small arteriolosclerosis lesions were seen alone in 14.8% of the autopsied brains, and relatively large infarcts were found in 36%.
At their yearly evaluations, study enrollees were assessed for Parkinsonian symptoms using a 26-item instrument derived from the Unified Parkinson's Disease Rating Scale. Each of the four major symptoms -- abnormal gait, bradykinesia, tremor, and rigidity -- were evaluated on 100-point scales. The average of these scores served as a global summary.
At death, the 418 individuals had had the following mean scores at their last evaluation:
•Gait: 41.5
•Rigidity: 11.7
•Bradykinesia: 21.4
•Tremor: 5.2
•Global summary: 18.6
Macroscopic infarcts were the most powerful predictors of these symptoms. Their presence was associated with increases of 0.359 points in the global score (P=0.013), 0.552 points on the gait scale (P=0.009), and 0.853 points on the rigidity scale (P<0.001).
Infarcts too small to be seen on imaging were associated with a 0.424-point increase in gait scores (P=0.047).
Arteriolosclerosis was a much smaller factor, although its association with gait scores (0.191 points, P<0.001) was statistically significant.
The location of infarcts within the brain appeared partly to determine their impact on parkinsonian signs. Multiple subcortical microinfarcts were more strongly associated with impaired gait (0.888 points, P=0.004) than cortical microinfarcts, the researchers found.
Similarly, subcortical macroscopic infarcts were also apparently more damaging than those within the cortex.
"Together these data suggest that a substantial portion of older people have brain tissue damage and small vessel disease that are unlikely to be detected before death and suggest that cerebrovascular disease may be an even larger public health challenge than currently estimated," Buchman and colleagues wrote.
They cited some limitations to the study. Microinfarcts and small arteriolosclerosis lesions were counted only in certain brain regions, potentially underestimating the association with parkinsonian signs. Study participants did not undergo brain imaging, so it is possible that signs of the cerebrovascular defects could be discernible in some cases.
Finally, the cross-sectional study design precludes firm conclusions about the direction of causality.
"It is possible that the cerebrovascular pathologies do not play a causal role in the development of parkinsonian signs, but rather both cerebrovascular pathologies and parkinsonian signs might be caused by a third factor," Buchman and colleagues noted.
The analysis was supported by the National Institutes of Health and the Illinois Department of Public Health.
Study authors declared they had no relevant financial interests.
Primary source: Stroke
Source reference:
Buchman A, et al "Cerebrovascular disease pathology and parkinsonian signs in old age" Stroke 2011; DOI: 10.1161/STROKEAHA.111.623462.
Susan Berg, dementia expert, shares practical help for caregivers of those with dementia including easy to do activities
Showing posts with label John Gever. Show all posts
Showing posts with label John Gever. Show all posts
Monday, October 3, 2011
Wednesday, January 20, 2010
Secondhand Smoke Linked to Adult Cognitive Impairment ( part 2 )
Here is a great dementia resource for caregivers and healthcare professinals,
Here is information on being the best caregiver you can be
Here are more interesting dementia brain boosting Corrier-journal.comactivities
Here is a dementia music activity
By John Gever, Senior Editor, MedPage Today
Reviewed by Robert Jasmer, MD; Associate Clinical Professor of Medicine, University of California, San Francisco . Earn CME/CE credit
for reading medical news
CAMBRIDGE, England,
Dr. Llewellyn and colleagues said earlier research had found an association between passive smoking and the risk of developing dementia, but those findings failed to reach statistical significance after adjusting for age, sex, and education. (See: AAN: Secondhand Smoke Can Add to Dementia Risk)
The researchers said the cognitive impairments seemingly associated with passive smoking may originate with the well-known vascular effects of tobacco. Over a long period, these effects could "compromise the blood supply to the brain," they wrote.
Arguing against that hypothesis was a finding in the current study that the presence or absence of cardiovascular disease, did not affect the results. Nevertheless, said Dr. Llewellyn and colleagues, "exposure to secondhand smoke may interact with subclinical cardiovascular disease."
In an accompanying editorial, Mark D. Eisner, M.D., M.P.H., of the University of California San Francisco, agreed that the study was additional evidence that secondhand smoke can impair brain function.
He also echoed the researchers' call for prospective studies, noting that cotinine was a marker only of tobacco exposure within the last day or so of sampling.
"Although recent exposure probably correlates with longer term exposure, studies that examine the longitudinal effect of self-reported lifetime exposure on cognitive impairment would strengthen the evidence of a causal association," Dr. Eisner said.
He added that, because dementia is such a frightening disorder, more publicity about it as an effect of public smoking may be an effective deterrent.
"Greater public awareness would eventually translate into political action aimed at passing smoke-free legislation in regions of the world where public smoking is still permitted," he contended.
The study was funded by the National Institute on Aging and several agencies of the British government.
No potential conflicts of interest were reported by study authors or the editorialist.
Here is information on being the best caregiver you can be
Here are more interesting dementia brain boosting Corrier-journal.comactivities
Here is a dementia music activity
By John Gever, Senior Editor, MedPage Today
Reviewed by Robert Jasmer, MD; Associate Clinical Professor of Medicine, University of California, San Francisco . Earn CME/CE credit
for reading medical news
CAMBRIDGE, England,
Dr. Llewellyn and colleagues said earlier research had found an association between passive smoking and the risk of developing dementia, but those findings failed to reach statistical significance after adjusting for age, sex, and education. (See: AAN: Secondhand Smoke Can Add to Dementia Risk)
The researchers said the cognitive impairments seemingly associated with passive smoking may originate with the well-known vascular effects of tobacco. Over a long period, these effects could "compromise the blood supply to the brain," they wrote.
Arguing against that hypothesis was a finding in the current study that the presence or absence of cardiovascular disease, did not affect the results. Nevertheless, said Dr. Llewellyn and colleagues, "exposure to secondhand smoke may interact with subclinical cardiovascular disease."
In an accompanying editorial, Mark D. Eisner, M.D., M.P.H., of the University of California San Francisco, agreed that the study was additional evidence that secondhand smoke can impair brain function.
He also echoed the researchers' call for prospective studies, noting that cotinine was a marker only of tobacco exposure within the last day or so of sampling.
"Although recent exposure probably correlates with longer term exposure, studies that examine the longitudinal effect of self-reported lifetime exposure on cognitive impairment would strengthen the evidence of a causal association," Dr. Eisner said.
He added that, because dementia is such a frightening disorder, more publicity about it as an effect of public smoking may be an effective deterrent.
"Greater public awareness would eventually translate into political action aimed at passing smoke-free legislation in regions of the world where public smoking is still permitted," he contended.
The study was funded by the National Institute on Aging and several agencies of the British government.
No potential conflicts of interest were reported by study authors or the editorialist.
Monday, January 18, 2010
Secondhand Smoke Linked to Adult Cognitive Impairment
Here is a great dementia resource for caregivers and healthcare professinals,
Here is information on being the best caregiver you can be
Here are more interesting dementia brain boosting Corrier-journal.comactivities
Here is a dementia music activity
By John Gever, Senior Editor, MedPage Today
Reviewed by Robert Jasmer, MD; Associate Clinical Professor of Medicine, University of California, San Francisco . Earn CME/CE credit
for reading medical news
CAMBRIDGE, England, Passive smoking can damage the brain of those 50 and older, researchers here said
Nonsmokers with the heaviest secondhand smoke exposure were at a 44% higher risk of scoring in the bottom 10% on cognitive testing, compared with those with the lowest level of passive smoking (P=0.02), reported David J. Llewellyn, Ph.D., of the University of Cambridge, and colleagues online in BMJ.
This result occurred after controlling for such potential confounding factors as age, sex, ethnicity, alcohol consumption, socioeconomic status, education, physical activity, body weight, medical history, depressive symptoms, and ex-smoker status.
"This analysis is to our knowledge the first to examine the relation between exposure to secondhand smoke and cognitive impairment in a large heterogeneous population-based sample," according to the researchers. Other studies have connected secondhand smoke exposure to impaired cognition in children and adolescents.
They said the findings were of "major public health significance" and called for additional, prospective studies to confirm and extend them.
The study involved 4,809 self-described nonsmokers at least 50 years old who participated in both of two large national health surveys and gave saliva samples.
One of the surveys, the English Longitudinal Study of Aging, included detailed cognitive testing that evaluated immediate and delayed verbal memory, attention and processing speed, prospective memory, numerical abilities, and semantic fluency.
Those in the bottom 10% of the combined cognitive score were considered impaired.
Cotinine, a nicotine metabolite that signals recent exposure to tobacco smoke, was measured in the saliva samples. Participants with cotinine levels higher than 14 ng/mL were excluded to ensure the study population did not contain clandestine tobacco users.
After adjusting for the potential confounding factors, the researchers found that people in the highest quartile of cotinine level -- 0.8 to 13.5 ng/mL -- had an odds ratio of 1.44 of being impaired (95% CI 1.07 to 1.94), relative to those in the lowest quartile.
Participants in the second and third quartiles showed small and statistically insignificant risks of cognitive impairment.
The relation between passive smoking exposure and cognitive impairment was strongest in participants who never smoked.
Never-smokers in the highest cotinine quartile had an odds ratio for impairment of 1.70 (95% CI 1.03 to 2.80). For ex-smokers with the heaviest smoke exposure, the odds ratio was 1.32 (95% CI 0.92 to 1.91).
Dr. Llewellyn and colleagues said.......more later
Here is information on being the best caregiver you can be
Here are more interesting dementia brain boosting Corrier-journal.comactivities
Here is a dementia music activity
By John Gever, Senior Editor, MedPage Today
Reviewed by Robert Jasmer, MD; Associate Clinical Professor of Medicine, University of California, San Francisco . Earn CME/CE credit
for reading medical news
CAMBRIDGE, England, Passive smoking can damage the brain of those 50 and older, researchers here said
Nonsmokers with the heaviest secondhand smoke exposure were at a 44% higher risk of scoring in the bottom 10% on cognitive testing, compared with those with the lowest level of passive smoking (P=0.02), reported David J. Llewellyn, Ph.D., of the University of Cambridge, and colleagues online in BMJ.
This result occurred after controlling for such potential confounding factors as age, sex, ethnicity, alcohol consumption, socioeconomic status, education, physical activity, body weight, medical history, depressive symptoms, and ex-smoker status.
"This analysis is to our knowledge the first to examine the relation between exposure to secondhand smoke and cognitive impairment in a large heterogeneous population-based sample," according to the researchers. Other studies have connected secondhand smoke exposure to impaired cognition in children and adolescents.
They said the findings were of "major public health significance" and called for additional, prospective studies to confirm and extend them.
The study involved 4,809 self-described nonsmokers at least 50 years old who participated in both of two large national health surveys and gave saliva samples.
One of the surveys, the English Longitudinal Study of Aging, included detailed cognitive testing that evaluated immediate and delayed verbal memory, attention and processing speed, prospective memory, numerical abilities, and semantic fluency.
Those in the bottom 10% of the combined cognitive score were considered impaired.
Cotinine, a nicotine metabolite that signals recent exposure to tobacco smoke, was measured in the saliva samples. Participants with cotinine levels higher than 14 ng/mL were excluded to ensure the study population did not contain clandestine tobacco users.
After adjusting for the potential confounding factors, the researchers found that people in the highest quartile of cotinine level -- 0.8 to 13.5 ng/mL -- had an odds ratio of 1.44 of being impaired (95% CI 1.07 to 1.94), relative to those in the lowest quartile.
Participants in the second and third quartiles showed small and statistically insignificant risks of cognitive impairment.
The relation between passive smoking exposure and cognitive impairment was strongest in participants who never smoked.
Never-smokers in the highest cotinine quartile had an odds ratio for impairment of 1.70 (95% CI 1.03 to 2.80). For ex-smokers with the heaviest smoke exposure, the odds ratio was 1.32 (95% CI 0.92 to 1.91).
Dr. Llewellyn and colleagues said.......more later
Subscribe to:
Posts (Atom)

